심혈관 정보 시스템(CVIS) 시장 예측(-2027년)

System Market

Worldwide it has been noticed that the cardiovascular information system market possesses a USD 1,560.93 million during the conjecture time of 2020 to 2027. It has been denoted that the cardiovascular information system market projects at a CAGR of 8.23%. Everywhere, it has been found that because of cardiovascular sickness many individuals have passed on because of heart-related infections.

The significant market driving elements are the ascent in the need to join CVIS with CPAS/EMR and different modules connected with cardiology to build the cardiovascular information system market size. Driving elements like interoperability, getting to the remote pictures and information, and limiting the responsibility of the IT area from the online emergency clinic is assisting in growing the cardiovascular information system with marketing size. The reception of CVIS coordinated arrangements because of its huge purchasing force of well-known emergency clinics and facilities expands the size of the cardiovascular information system market in this end-client order.

Market Segmentation

Based on type, the cardiovascular information system market is separated into CVIS and C-PACS. The CVIS division involves a huge market share from estimated time of 2015 to 2020. The CVIS area examines the information well and empowers the specialists to complete the ideal choice in very little time. In view of sections, the market is separated into programming, administration, and equipment.

Innovation progression of innovation prompted the utilization of imaging strategies for the treatment of related messes. Cutting-edge innovation has assisted in unique announcing of the pictures in the cardiovascular information system with marketing which has helped in conveying the reports of the patients.

Regional Analysis

The cardiovascular information system market is extended to a great extent to the districts of North America coming after the European locale. Topographically, it has been denoted that this North American district is predominantly involved by severe protection and security guidelines and ascend in the extension of business in the cardiovascular information area. Universally, the North American locale has a medical services information system that has fostered its organization with merchants. Latin America is supposed to be somewhat in reverse than other arising nations yet is as yet encountering enormous potential for cardiovascular information system market development during the market figure period.

Major Players

The major market players of the global cardiovascular information system are GE, Koninklijke Philips N.V., McKesson Corporation, Siemens Healthineers, IBM Watson Health, Fujifilm Holdings Corporation, and Cerner Corporation.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

LIST OF CONTENTS

1 EXECUTIVE SUMMARY 18

2 MARKET INTRODUCTION 19

• 2.1 SCOPE OF THE STUDY 19
• 2.2 RESEARCH OBJECTIVE 19
• 2.3 MARKET STRUCTURE 19
• 2.4 ASSUMPTIONS & LIMITATIONS 20

3 RESEARCH METHODOLOGY 21

• 3.1 DATA MINING 21
• 3.2 SECONDARY RESEARCH 22
• 3.3 PRIMARY RESEARCH 23
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24
• 3.5 FORECASTING TECHNIQUES 24
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26
  • 3.6.1 BOTTOM-UP APPROACH 27
  • 3.6.2 TOP-DOWN APPROACH 27
• 3.7 DATA TRIANGULATION 28
• 3.8 VALIDATION 28

4 MARKET DYNAMICS 29

• 4.1 OVERVIEW 29
• 4.2 DRIVERS 30
  • 4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES 30
  • 4.2.2 GROWING GOVERNMENT INITIATIVES TOWARDS THE IMPLEMENTATION OF ELECTRONIC HEALTH RECORD SYSTEM 30
  • 4.2.3 TECHNOLOGICAL ADVANCEMENTS 30
  • 4.2.4 RISING DEMAND FOR DATA-DRIVEN TECHNOLOGIES 31
• 4.3 RESTRAINTS 32
  • 4.3.1 HIGH COST OF CVIS FOLLOWED BY THE NEED FOR TRAINING 32
  • 4.3.2 RESTRAINT IMPACT ANALYSIS 32
• 4.4 OPPORTUNITIES 32
  • 4.4.1 EMERGING MARKETS OF CVIS 32

5 MARKET FACTOR ANALYSIS 33

• 5.1 VALUE CHAIN ANALYSIS 33
  • 5.1.1 R&D 34
  • 5.1.2 MANUFACTURING 34
  • 5.1.3 DISTRIBUTION AND SALES 34
  • 5.1.4 POST-SALES MONITORING 34
• 5.2 PORTER'S FIVE FORCES MODEL 35
  • 5.2.1 BARGAINING POWER OF SUPPLIERS 35
  • 5.2.2 BARGAINING POWER OF BUYERS 36
  • 5.2.3 THREAT OF NEW ENTRANTS 36
  • 5.2.4 THREAT OF SUBSTITUTES 36
  • 5.2.5 INTENSITY OF RIVALRY 36
• 5.3 IMPACT OF COVID-19 ON THE CARDIOVASCULAR INFORMATION SYSTEM MARKET 36
  • 5.3.1 OVERVIEW 36
  • 5.3.2 IMPACT ON PRIVACY 37
  • 5.3.3 IMPACT ON TECHNOLOGY 37
  • 5.3.4 IMPACT ON DEMAND 37

6 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT 38

• 6.1 OVERVIEW 38
• 6.2 SOFTWARE 39
• 6.3 SERVICES 39
• 6.4 HARDWARE 40

7 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE 41

• 7.1 OVERVIEW 41
• 7.2 CLOUD-BASED/WEB-BASED 42
• 7.3 ON-PREMISE 42

8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION 43

• 8.1 OVERVIEW 43
• 8.2 CARDIAC AND PERIPHERAL CATHETERIZATION 44
• 8.3 ECHOCARDIOGRAPHY 45
• 8.4 HEMODYNAMICS MONITORING 45
• 8.5 ELECTROPHYSIOLOGY 46
• 8.6 VASCULAR ULTRASOUND 46
• 8.7 NUCLEAR CARDIOLOGY 47
• 8.8 ECG/STRESS/HOLTER MANAGEMENT 47
• 8.9 OTHERS 48

9 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER 49

• 9.1 OVERVIEW 49
• 9.2 HOSPITAL & CLINICS 50
• 9.3 DIAGNOSTIC LABORATORIES 50
• 9.4 CARDIAC CATH LABS 51
• 9.5 OTHERS 51

10 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 52

• 10.1 OVERVIEW 52
• 10.2 AMERICAS 53
• 10.3 NORTH AMERICA 56
  • 10.3.1 US 58
  • 10.3.2 CANADA 59
  • 10.3.3 LATIN AMERICA 61
• 10.4 EUROPE 63
  • 10.4.1 WESTERN EUROPE 65
    • 10.4.1.1 GERMANY 68
    • 10.4.1.2 FRANCE 69
    • 10.4.1.3 UK 71
    • 10.4.1.4 ITALY 72
    • 10.4.1.5 SPAIN 74
    • 10.4.1.6 REST OF WESTERN EUROPE 76
  • 10.4.2 EASTERN EUROPE 77
• 10.5 ASIA-PACIFIC 79
  • 10.5.1 CHINA 81
  • 10.5.2 INDIA 83
  • 10.5.3 JAPAN 84
  • 10.5.4 AUSTRALIA 86
  • 10.5.5 SOUTH KOREA 87
  • 10.5.6 REST OF ASIA-PACIFIC 89
• 10.6 MIDDLE EAST & AFRICA 90
  • 10.6.1 MIDDLE EAST 93
  • 10.6.2 AFRICA 94

11 COMPETITIVE LANDSCAPE 96

• 11.1 OVERVIEW 96
• 11.2 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96
• 11.3 COMPETITIVE BENCHMARKING 97
• 11.4 COMPETITOR DASHBOARD 98
• 11.5 DEVELOPMENTS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98
  • 11.5.1 ACQUISITION 98
  • 11.5.2 COLLABORATION 99
  • 11.5.3 PRODUCT LAUNCH 99
  • 11.5.4 PARTNERSHIP 99
• 11.6 FINANCIAL MATRIX 100

12 COMPANY PROFILES 101

• 12.1 GE HEALTHCARE 101
  • 12.1.1 COMPANY OVERVIEW 101
  • 12.1.2 FINANCIAL OVERVIEW 102
  • 12.1.3 PRODUCTS/SERVICES OFFERED 102
  • 12.1.4 KEY DEVELOPMENTS 103
  • 12.1.5 SWOT ANALYSIS 103
  • 12.1.6 KEY STRATEGIES 103
• 12.2 SIEMENS HEALTHINEERS 104
  • 12.2.1 COMPANY OVERVIEW 104
  • 12.2.2 FINANCIAL OVERVIEW 105
  • 12.2.3 PRODUCTS/SERVICES OFFERED 105
  • 12.2.4 KEY DEVELOPMENTS 106
  • 12.2.5 SWOT ANALYSIS 106
  • 12.2.6 KEY STRATEGIES 106
• 12.3 KONINKLIJKE PHILIPS NV 107
  • 12.3.1 COMPANY OVERVIEW 107
  • 12.3.2 FINANCIAL OVERVIEW 108
  • 12.3.3 PRODUCTS/SERVICES OFFERED 108
  • 12.3.4 KEY DEVELOPMENTS 109
  • 12.3.5 SWOT ANALYSIS 109
  • 12.3.6 KEY STRATEGIES 109
• 12.4 FUJIFILM HOLDINGS CORPORATION 110
  • 12.4.1 COMPANY OVERVIEW 110
  • 12.4.2 FINANCIAL OVERVIEW 111
  • 12.4.3 PRODUCTS/SERVICES OFFERED 111
  • 12.4.4 KEY DEVELOPMENTS 112
  • 12.4.5 SWOT ANALYSIS 112
  • 12.4.6 KEY STRATEGIES 112
• 12.5 MCKESSON CORPORATION 113
  • 12.5.1 COMPANY OVERVIEW 113
  • 12.5.2 FINANCIAL OVERVIEW 114
  • 12.5.3 PRODUCTS/SERVICES OFFERED 114
  • 12.5.4 KEY DEVELOPMENTS 115
  • 12.5.5 SWOT ANALYSIS 115
  • 12.5.6 KEY STRATEGIES 116
• 12.6 CERNER CORPORATION 117
  • 12.6.1 COMPANY OVERVIEW 117
  • 12.6.2 FINANCIAL OVERVIEW 117
  • 12.6.3 PRODUCTS OFFERED 118
  • 12.6.4 KEY DEVELOPMENTS 118
  • 12.6.5 SWOT ANALYSIS 119
  • 12.6.6 KEY STRATEGIES 119
• 12.7 IBM WATSON HEALTH 120
  • 12.7.1 COMPANY OVERVIEW 120
  • 12.7.2 FINANCIAL OVERVIEW 121
  • 12.7.3 PRODUCTS OFFERED 121
  • 12.7.4 KEY DEVELOPMENTS 122
  • 12.7.5 SWOT ANALYSIS 122
  • 12.7.6 KEY STRATEGIES 123
• 12.8 LUMEDX 124
  • 12.8.1 COMPANY OVERVIEW 124
  • 12.8.2 FINANCIAL OVERVIEW 124
  • 12.8.3 PRODUCTS OFFERED 124
  • 12.8.4 KEY DEVELOPMENTS 124
  • 12.8.5 SWOT ANALYSIS 125
  • 12.8.6 KEY STRATEGIES 125
• 12.9 AGFA-GEVAERT N.V. 126
  • 12.9.1 COMPANY OVERVIEW 126
  • 12.9.2 FINANCIAL OVERVIEW 126
  • 12.9.3 PRODUCTS OFFERED 126
  • 12.9.4 KEY DEVELOPMENTS 127
  • 12.9.5 SWOT ANALYSIS 127
  • 12.9.6 KEY STRATEGIES 127
• 12.10 DIGISONICS INC. 128
  • 12.10.1 COMPANY OVERVIEW 128
  • 12.10.2 FINANCIAL OVERVIEW 128
  • 12.10.3 PRODUCTS OFFERED 128
  • 12.10.4 KEY DEVELOPMENTS 128
  • 12.10.5 SWOT ANALYSIS 129
  • 12.10.6 KEY STRATEGIES 129
• 12.11 CARESTREAM HEALTH 130
  • 12.11.1 COMPANY OVERVIEW 130
  • 12.11.2 FINANCIAL OVERVIEW 130
  • 12.11.3 PRODUCTS/SERVICES OFFERED 130
  • 12.11.4 KEY DEVELOPMENTS 130
  • 12.11.5 SWOT ANALYSIS 131
  • 12.11.6 KEY STRATEGIES 131
• 12.12 EPIC SYSTEMS CORPORATION 132
  • 12.12.1 COMPANY OVERVIEW 132
  • 12.12.2 FINANCIAL OVERVIEW 132
  • 12.12.3 PRODUCTS OFFERED 132
  • 12.12.4 KEY DEVELOPMENTS 132
  • 12.12.5 SWOT ANALYSIS 133
  • 12.12.6 KEY STRATEGIES 133
• 12.13 SCIMAGE, INC. 134
  • 12.13.1 COMPANY OVERVIEW 134
  • 12.13.2 FINANCIAL OVERVIEW 134
  • 12.13.3 PRODUCTS/SERVICES OFFERED 134
  • 12.13.4 KEY DEVELOPMENTS 134
  • 12.13.5 SWOT ANALYSIS 135
  • 12.13.6 KEY STRATEGIES 135

13 APPENDIX 136

• 13.1 REFERENCES 136
• 13.2 RELATED REPORTS 136